Inclusion of Children in Clinical Trials of Treatments for COVID-19

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 7, 2020

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.1888?guestAccessKey=57a0058e-496b-4d2a-8b8d-aa6a54a8feb7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050720

 

What Viewpoint Says: This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Authors: Florence T. Bourgeois, M.D., M.P.H., of Boston Children’s Hospital and Harvard Medical School is Boston, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2020.1888)

Editor’s Note:  The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.